The WFH Clinical Research Grant Program (CRGP) provides support for international clinical investigations related to inherited bleeding disorders. Since the grant program was launched in April 2013, over $430,000 has been disbursed to 10 grant recipients.
The CRGP is now in its fourth cycle of grant competition and the process has been updated in several ways for the 2017 submission year.
GRANT AMOUNT AND DURATION
The CRGP will award up to four grants per year for the best proposals that address critical clinical issues of broad international significance. The grant amount is $10,000 to $50,000 per year, per grant. Funding is awarded for up to two years.
The WFH Medical Advisory Board and the WFH Research Committee have identified research priorities for grant applications. Submissions do not need to be limited to this list, however, research proposals that fall within these priorities are strongly encouraged.
1. Prophylaxis schedules
2. Inhibitor diagnosis and management
3. Optimal use of adjunctive therapies
4. Care of the neonate with hemophilia
5. Management of chronic hemophilic arthropathy
6. Care of hemophilia carriers
7. Pain management
8. Role of physical activity in hemophilia care
9. Management of special bleeds (for example, ileopsoas, renal)
10. Role of arthrocentesis in hemophilia care
11. Management of cardiovascular disease in hemophilia
12. von Willebrand disease and rare bleeding disorders
The initial letter of intent and abbreviated CV are due on February 1, 2017. Shortlisted candidates will be notified in March and invited to submit a full research project by May 15, 2017.